WallStSmart
CBUS

Cibus Global LLC

NASDAQ: CBUS · HEALTHCARE · BIOTECHNOLOGY

$1.40
+9.37% today

Updated 2026-04-30

Market cap
$114.42M
P/E ratio
P/S ratio
31.44x
EPS (TTM)
$-2.78
Dividend yield
52W range
$1 – $4
Volume
0.7M

Cibus Global LLC (CBUS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-86.5%
Last 4 quarters
Revenue YoY growth
-12.8%
Most recent quarter
EPS YoY growth
+52.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-18.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-27.7%
2026-03-18
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.42-178.1%$3.68$2.66-27.7%
2025-11-13$-0.44-91.3%$1.35$1.22-9.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.15$-0.42-178.1%$1.06M-12.8%
2025-09-30$-0.23$-0.44-91.3%$615000.00-63.1%
2025-06-30$-0.30$-0.61-103.3%$933000.00+11.3%
2025-03-31$-1.01$-0.74+26.7%$1.03M+89.7%
2024-12-31$-0.76$-0.87-14.5%$1.21M+9.9%
2024-09-30$-0.89$-7.63-757.3%$1.67M+250.9%
2024-06-30$-0.81$-1.14-40.7%$838000.00+325.4%
2024-03-31$-1.01$-1.12-10.9%$545000.00+1197.6%
2023-12-31$-1.43$-12.59-780.4%$1.10M
2023-09-30$-1.17$-1.59-35.9%$475000.00
2023-06-30$-0.30$-3.05-916.7%$197000.00
2023-03-31$-3.00$-5.45-81.7%$42000.00

Frequently asked questions

Has Cibus Global LLC beaten earnings estimates?
Cibus Global LLC has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -86.5% over the last 4 quarters.
How does CBUS stock react to earnings?
CBUS stock has moved an average of -18.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Cibus Global LLC's revenue growth rate?
Cibus Global LLC reported year-over-year revenue growth of -12.8% in its most recent quarter, with EPS growing +52.1% year-over-year.